King Luther Capital Management Corp Has $4.54 Million Holdings in Phreesia, Inc. $PHR

Key Points

• King Luther Capital Management increased its Phreesia stake by 172.6% in the fourth quarter, ending with 268,314 shares valued at about $4.54 million.
• Phreesia’s latest quarterly results beat expectations, with EPS of $0.05 versus $0.02 expected and revenue of $130.94 million, up 12.9% year over year.
• Analyst sentiment is mixed: the consensus rating remains Hold, while recent moves included Citigroup raising its target to $12 and Piper Sandler downgrading the stock to neutral amid ongoing litigation concerns.

King Luther Capital Management Corp grew its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 172.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 268,314 shares of the company's stock after buying an additional 169,900 shares during the quarter. King Luther Capital Management Corp owned 0.45% of Phreesia worth $4,540,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in PHR. Millennium Management LLC boosted its holdings in shares of Phreesia by 730.7% in the third quarter. Millennium Management LLC now owns 1,064,132 shares of the company's stock valued at $25,028,000 after buying an additional 936,033 shares during the period. Greenhouse Funds LLLP boosted its holdings in shares of Phreesia by 16.8% in the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company's stock valued at $91,317,000 after buying an additional 557,265 shares during the period. Bessemer Group Inc. boosted its holdings in shares of Phreesia by 1,065.9% in the third quarter. Bessemer Group Inc. now owns 554,513 shares of the company's stock valued at $13,043,000 after buying an additional 506,954 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Phreesia by 8.3% in the third quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company's stock valued at $134,177,000 after purchasing an additional 437,462 shares in the last quarter. Finally, Qube Research & Technologies Ltd lifted its holdings in shares of Phreesia by 87.4% in the third quarter. Qube Research & Technologies Ltd now owns 730,054 shares of the company's stock valued at $17,171,000 after purchasing an additional 340,535 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on PHR. Citigroup boosted their price target on Phreesia from $10.00 to $12.00 and gave the company a "neutral" rating in a report on Thursday. Mizuho cut their price target on Phreesia from $22.00 to $19.00 and set an "outperform" rating on the stock in a report on Tuesday, March 24th. Wells Fargo & Company restated an "equal weight" rating and issued a $9.00 price target (down from $15.00) on shares of Phreesia in a report on Wednesday, May 20th. Wall Street Zen lowered Phreesia from a "buy" rating to a "hold" rating in a report on Saturday, April 4th. Finally, Citizens Jmp reiterated a "market perform" rating on shares of Phreesia in a report on Wednesday, April 1st. Nine research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Phreesia presently has a consensus rating of "Hold" and an average price target of $16.65.

Phreesia Price Performance

Shares of NYSE PHR opened at $9.45 on Friday. The stock has a market capitalization of $583.79 million, a price-to-earnings ratio of 63.01 and a beta of 0.89. The business has a 50-day moving average of $9.49 and a 200-day moving average of $13.60. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.53 and a quick ratio of 1.53. Phreesia, Inc. has a fifty-two week low of $7.77 and a fifty-two week high of $32.76.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. The company had revenue of $130.94 million during the quarter, compared to analysts' expectations of $130.08 million. Phreesia had a return on equity of 5.30% and a net margin of 1.85%.Phreesia's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.07) EPS. As a group, sell-side analysts predict that Phreesia, Inc. will post 0.28 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider David Linetsky sold 8,332 shares of the firm's stock in a transaction dated Friday, April 10th. The stock was sold at an average price of $8.07, for a total value of $67,239.24. Following the completion of the transaction, the insider owned 224,056 shares in the company, valued at $1,808,131.92. This trade represents a 3.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Yvonne Hui sold 10,063 shares of the stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $9.08, for a total value of $91,372.04. Following the completion of the sale, the insider directly owned 25,991 shares of the company's stock, valued at approximately $235,998.28. The trade was a 27.91% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 50,493 shares of company stock worth $461,983 over the last 90 days. 5.20% of the stock is currently owned by insiders.

Key Stories Impacting Phreesia

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia reported first-quarter fiscal 2027 results that beat expectations, with EPS of $0.05 versus $0.02 expected and revenue of $130.94 million topping estimates. Management also pointed to 12.9% year-over-year revenue growth and said it is entering fiscal 2027 with strong momentum and several growth initiatives. Phreesia Announces First Quarter Fiscal 2027 Results
• Positive Sentiment: DA Davidson reiterated a Buy rating and set a $14 price target, suggesting meaningful upside from current levels. Piper Sandler also has a higher target than the recent trading price, even though it lowered its stance to neutral. DA Davidson Reiterates Buy Rating on Phreesia Inc. (PHR)
• Neutral Sentiment: Analysts and market commentary highlighted that the company’s outlook remains tied to continued execution in its Network Solutions segment and broader healthcare platform, making the earnings beat important for confirming the growth story. Phreesia Inc (PHR) Q1 2027 Earnings Call Highlights
• Negative Sentiment: Multiple law firms issued fresh class-action reminders and deadline notices related to allegations that Phreesia made misleading statements about growth prospects, especially in its Network Solutions segment. This keeps litigation risk in focus and can weigh on sentiment. Lost Money on Phreesia, Inc. (PHR)? Join Class Action Suit Seeking Recovery
• Negative Sentiment: Piper Sandler downgraded Phreesia from overweight to neutral, signaling a more cautious view even as it maintained a $12 price target. Piper Sandler Downgrades Phreesia from Overweight to Neutral

Phreesia Profile

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.